SHINSUKE SASADA

Last Updated :2023/02/02

Affiliations, Positions
Hiroshima University Hospital, Assistant Professor
E-mail
shsasadahiroshima-u.ac.jp
Self-introduction
He is a breast cancer specialist. His research interests are development of breast imaging using microwave and nuclear medicine.

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Intensive, Introduction to clinical clerkship
  2. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  3. 2022, Undergraduate Education, Intensive, Practice of Medicine II
  4. 2022, Undergraduate Education, First Semester, Surgery I

Research Activities

Academic Papers

  1. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer, Anticancer Research, 43(1), 127-136, 2023
  2. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy, Breast Cancer, 30(1), 151-155, 2023
  3. Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences, Ann Surg Oncol, 2022
  4. Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan, Breast Cancer, 2022
  5. The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively, J Med Ultrason, 49(4), 709-717, 2022
  6. Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer, Breast, 65, 98-103, 202210
  7. The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer, Discov Oncol, 13(1), 27, 2022
  8. The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer, Surg Oncol, 41, 101725, 2022
  9. Malignant prediction of incidental findings using ring‑type dedicated breast positron emission tomography, Sci Rep, 12(1), 1144, 2022
  10. Four patterns of abnormal ring-like uptakes on dedicated breast PET, Clin Nucl Med, 47(2), e192-e193, 2022
  11. Monitoring of programmed cell death ligand-1 blockade using FDG PET/CT for microsatellite instability-high metastatic breast cancer, Clin Nucl Med, e252-e253, 2022
  12. Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer, Anticancer Research, 42(12), 5945-5949, 2022
  13. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer, Breast Cancer Res Treat, 187, 125-133, 2021
  14. Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast Cancer, Cancer Diagnosis & Prognosis, 1(4), 309-316, 2021
  15. Bloodstream Infection Caused by Actinomyces neuii subsp. anitratus in a Patient with Breast Cancer: A Case Report and Literature Review, Hiroshima J Med Sci, 70(2-4), 43-47, 2021
  16. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors, Eur J Surg Oncol, 47, 1588-1592, 2021
  17. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis, Breast Cancer, 2021
  18. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer. Breast Cancer, Breast Cancer, 2021
  19. Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy, Invest New Drugs, 38(2), 485-492, 2020
  20. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles, Cancer Science, 111(6), 2104-2115, 2020
  21. Diagnostic Performance of Peripheral Leukocyte Telomere G-tail Length for Detecting Breast Cancer, Cancer Science, 111(5), 1856-1861, 2020
  22. Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer, Anticancer Research, 40(6), 3395-3400, 2020
  23. Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer, Anticancer Research, 40(6), 3491-3497, 2020
  24. Fertility preservation in breast cancer treatment: Initiatives in Hiroshima Prefecture, Hiroshima Igaku, 73(5), 333-338, 2020
  25. Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study, JMIR RESEARCH PROTOCOLS, 9(10), 2020
  26. A Two-Stage Rotational Surface Clutter Suppression Method for Microwave Breast Imaging With Multistatic Impulse-Radar Detector, IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT, 69(12), 9586-9598, 2020
  27. CMOS Gaussian Monocycle Pulse Transceiver for Radar-Based Microwave Imaging, IEEE Trans Biomed Circuits Syst, 14(6), 1333-1345, 2020
  28. Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer, Support Care Cancer, 29, 3507-3512, 2020
  29. A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma., J Gynecol Oncol, 30, e8, 2019
  30. Detectability of Breast Tumors in Excised Breast Tissues of Total Mastectomy by IR-UWB-Radar-Based Breast Cancer Imaging, IEEE Trans Biomed Eng, 2019
  31. Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT, Eur J Nucl Med Mol Imaging, 46(4), 831-837, 2019
  32. Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer, Breast Cancer, 26(5), 573-580, 2019
  33. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer, Breast Cancer Res Treat, 177(3), 651-657, 2019
  34. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT, AJR Am J Roentgenol, 213(5), 1129-1135, 2019
  35. Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan, Cancer Chemother Pharmacol, 84(5), 1051-1058, 2019
  36. Therapeutic value of postmastectomy radiation therapy for T1-2 breast cancer with 1-3 positive lymph nodes, JOURNAL OF RADIATION ONCOLOGY, 8(3), 323-328, 2019
  37. Proposals and challenges of lecture to high school girls, aiming to spread of correct knowledge and improve screening rate of breast cancer, J.Jpn.Assoc.Breast Cancer Screen, 28(2), 89-92, 2019
  38. Baseline risk of recurrence in stage I-II endometrial carcinoma, Journal of Gynecologic Oncology, 29(1), e9, 2018
  39. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study, European Journal of Surgical Oncology, 44(4), 444-448, 2018
  40. Clinical experience and prospect of dedicated breast PET, New Medicine, 45(3), 51-54, 2018
  41. The differences in histological changes among pulmonary vessels divided with an energy device, Interact Cardiovasc Thorac Surg, 2018
  42. Current status of postmastectomy radiation therapy in T1-2 breast cancer with limited positive lymph nodes in Japan: Japan Clinical Oncology Group Survey, Breast Cancer, 2018
  43. Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer, Oncotarget, 9(30), 20979-20992, 2018
  44. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer, Breast Cancer Res Treat, 2018
  45. Which type of breast cancers is undetectable on ring-type dedicated breast PET?, Clin Imaging, 2018
  46. Portable impulse-radar detector for breast cancer: a pilot study, J Med Imaging, 5(2), 025502, 2018
  47. Using Elmammo to determine response to neo-adjuvant chemotherapy for breast cancer, MEDICAL NOW, 83, 20-23, 2018
  48. Visualization of HER2-specific breast cancer intratumoral heterogeneity using (64)Cu-DOTA-trastuzumab PET., European journal of nuclear medicine and molecular imaging, 44(12), 2146-2147, 2017
  49. 64Cu-DOTA-Trastuzumab PET imaging for HER2-specific primary lesions of breast cancer, Annals of Oncology, 28(8), 2028-2029, 2017
  50. Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience, Investigational New Drugs, 25(3), 392-396, 2017
  51. Development and clinical application of molecular imaging, Jpn J Clin Med, 75(3), 177-180, 2017
  52. Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy, Internal Medicine, 2017
  53. Detectability of Breast Tumor by a Hand-held Impulse-Radar Detector: Performance Evaluation and Pilot Clinical Study, Scientific Reports, 7(1), 16353, 2017
  54. Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy, INTERNAL MEDICINE, 56(21), 2879-2882, 2017
  55. HER2-PET imaging and tracking breast cancer drug pharmacokinetics, Japanese Journal of Breast Cancer, 31(1), 29-36, 2016
  56. Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults, Anticancer Research, 36(5), 2429-2432, 2016
  57. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma, Clinical Lung Cancer, 17(5), 433-440, 2016
  58. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(11), 1015-1021, 2016
  59. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 102(5), 1668-1673, 2016
  60. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 49(1), 293-299, 2016
  61. Comparison of Malignant Grade Between Pure and Partially Invasive Types of Early Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 99(3), 956-960, 2015
  62. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 100(6), 2079-2086, 2015
  63. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma, LUNG CANCER, 90(2), 199-204, 2015
  64. Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 149(4), 982-988, 2015
  65. Analysis of infections related to totally implantable central venous access devices, Surgery, 76(10), 1148-1151, 2014
  66. Developments and perspectives of adjuvant chemotherapy for resected lung cancer, Clinical Oncology, 13(1), 73-78, 2014
  67. Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 98(2), 417-423, 2014
  68. A patient continued anti-cancer treatment because of effective colostomy against pain with defection by local recurrence of rectal cancer, Jpn J Cancer Chemother, 40(6), 811-813, 2013
  69. A case of metastatic small intestinal tumor from primary lung cancer with hemorrhage and a high G-CSF serum level, Jpn J Cancer Chemother, 40(6), 777-780, 2013
  70. Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil, ONCOLOGY REPORTS, 29(3), 925-931, 2013
  71. A case of small bowel obstructiion with trichobezoar, Surgery, 73(11), 1229-1231, 2011
  72. A case of early adenosquamous carcinoma of the stomach, Surgery, 73(5), 542-544, 2011
  73. Significance of serum-albumin and albumin injection for pancreatic fistula after pancreaticoduodenectomy, Surgery, 73(2), 205-210, 2011
  74. A case of hepatocellular carcinoma with the right-sided round ligament treated by hepatectomy, Surgery, 72(5), 555-557, 2010
  75. Case report of pseudoaneurysm cased by core needle biopsy of the breast, Breast Cancer, 17(1), 75-78, 2010
  76. Survival of patients treated by an autonomic nerve-preserving gastrectomy for early gastric cancer, SURGERY TODAY, 40(5), 444-450, 2010
  77. Well-differentiated endocrine cell carcinoma of ileum treated by laparoscopy-assisted surgery--a case report, Hiroshima Journal of Medical Sciences, 59(2), 35-38, 2010
  78. A case of long-term survival in P1CY1 gastric cancer responding to combined chemotherapy with low-dose CDDP intraperitoneal administration, Jpn J Cancer Chemother, 36(12), 2061-2063, 2009
  79. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer, Anticancer Research, 29(8), 3347-3351, 2009
  80. Clinical Signifiance of Preoperative PET/CT Examination for Breast Cancer, Med J Hiroshima City Hosp, 59, 35-38, 2009
  81. A Case of External Supravesical Hernia Requiring Small Bowel Resection, Iryo, 62(8), 427-429, 2008
  82. Clinical Effect of Vinorelbine Monotherapy in 18 Cases of Advanced or Metastatic Breast Cancer, Jpn J Cancer Chemother, 35(10), 1703-1707, 2008
  83. A Case of Recurrent Breast Cancer with Bone Marrow Metastasis Treated with Weekly Paclitaxel Therapy, Jpn J Cancer Chemother, 35(9), 1611-1613, 2008
  84. A Case of Long Survival of a Scirrhous Gastric Cancer Patient with Esophageal Invasion and Peritoneal Dissemination through Chemotherapy and Patliative Surgery, Jpn J Cancer Chemother, 35(9), 1551-1554, 2008
  85. Characteristics of gastric cancer in patients over 80-years-old, Hepatogastroenterology, 55(86-87), 1931-1934, 2008
  86. A Case of Reconstructive Gastric Tube Necrosis 6 months after Esophagectomy, Jpn J Gastroenterol Surg, 40(9), 1565-1569, 2007
  87. A Case of Retroperitoneal Extraskeltal Osteosarcoma Producing Bone Marrow, Journal of Japan Surgical Association, 68(7), 1826-1830, 2007
  88. A Case of Acute Arterial Occlusion of the Upper Extremity Due to Thoracic Outlet Syndrome, Jpn J Vasc Surg, 15(3), 409-412, 2006

Publications such as books

  1. 2022/06/30, Breast Oncology 4th ed, KANEHARA & Co., LTD, 2022, Scholarly Book, Contributor, 978-4-307-20450-7
  2. 2022/07/04, The Japanese Breast Cancer Society Clinical Practice Guidelines, 2022 ed, KANEHARA & Co., LTD, 2022, Scholarly Book, Contributor, 978-4-307-20441-5
  3. 2021/11/30, Biomedical Engineering, Microwave Imaging for Breast Cancer Screening, Jenny Stanford Publishing, 2021, Scholarly Book, Joint work, English, Kikkawa T, Song H, Arihiro K, Sasada S, 9781003141945, 396, 41

Invited Lecture, Oral Presentation, Poster Presentation

  1. Relationship between febrile neutropenia and oral bacteria in breast cancer chemotherapy, Sasada S, Nishi H, Emi A, Masumoto N, Kadoya T, Okada M, the 2022 Japanese Society of Medical Oncology Annual Congress, 2022/02, Without Invitation, Japanese, Kyoto
  2. Nationwide database study in Japan: Immediate breast reconstruction for patients with breast cancer, Sasada S, Hayashi N, Kumamaru H, The 30th Annual Meeting of the Japanese Breast Cancer, 2022/07, With Invitation, Japanese, Yokohama
  3. Change in working schedule of a male breast surgeon after taking childcare leave, Sasada S, Masumoto N, Emi A, Kadoya T, Okada M, The 30th Annual Meeting of the Japanese Breast Cancer, 2022/07, Without Invitation, Japanese, Yokohama
  4. Breast Cancer Imaging. Standard imaging of breast cancer and experimental microwave breast imaging, Sasada S, Research Institute for Nanodevice and Bio Systems International Workshop on Nanodevice Technologies 2017, 2017/11/07, With Invitation, English, Hiroshima
  5. Dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors, Sasada S, Masumoto N, Ikejiri H, Kaneko Y, Kai A, Kawamata A, Hiraoka E, Emi A, Kadoya T, Okada M, The 29th Annual Meeting of the Japanese Breast Cancer, 2021/07, Without Invitation, Japanese
  6. What we get from taking childcare leave of a male breast surgeon?, Sasada S, Masumoto N, Emi A, Kadoya T, Okada M, The 121th Annual Congress of Japanese Surgical Society, 2021/04, Without Invitation, Japanese
  7. Male Breast Surgeons' Involvement in Workplace Reform and Promotion of Women's Activities, Sasada S, Masumoto N, Nishina M, Kimura Y, Amioka A, Itagaki T, Emi A, Kadoya T, Okada M, The 28th Annual Meeting of the Japanese Breast Cancer, 2020/10, Without Invitation, Japanese, Web
  8. PET-TIL score for predicting response to neoadjuvant chemotherapy for breast cancer, Sasada s, Kimura Y, Nishina M, Amioka A, Itagaki T, Emi A, Masumoto N, Kadoya T, Okada M, The 120th Annual Congress of Japanese Surgical Society, 2020/08, Without Invitation, Japanese, Web
  9. Classification of abnormal findings on ring-type dedicated breast PET for detecting breast cancer, Sasada S, Masumoto N, Nishina M, Kimura Y, Amioka A, Itagaki T, Emi A, Kadoya T, Okada M, ESMO 2019, 2019/09/30, Without Invitation, English
  10. Oral environment and febrile neutropenia during docetaxel plus cyclophosphamide chemotherapy in breast cancer, Sasada S, Nishi H, Goda N, Emi A, Kajitani K, Masumoto N, Kadoya T, Okada M, 2019 the Japanese Society of Medical Oncology Annual Meeting, 2019/07/18, Without Invitation, Japanese
  11. Process of pathological assessment of sentinel lymph node affects axillary diagnostic accuracy and adjuvant chemotherapy, Sasada S, Masumot N, Sueoka S, Suzuki E, Goda N, Kajitani K, Emi A, Haruta R, Kadoya T, Kataoka T, Okada M, 27th Annual Meeting of the Japanese Breast Cancer Society, 2019/07/12, Without Invitation, Japanese
  12. Hand-held impulse-radar detector for breast cancer: development and a pilot study, Sasada S, Masumoto N, Song H, Goda N, Kajitani K, Emi A, Kadoya T, Arihiro K, Kikkawa T, Okada M, San Antonio Breast Cancer Symposium 2018, 2018/12/08, Without Invitation, English, San Antonio
  13. Relationship between ring-type dedicated breast PET and tumor-infiltrating lymphocytes in early breast cancer, Sasada S, Shiroma N, Suzuki E, Sueoka S, Goda N, Kajitani K, Emi A, Masumoto N, Kadoya T, Haruta R, Kataoka T, Arihiro K, Okada M, ESMO 2018 Congress, 2018/10/20, Without Invitation, English, Munich
  14. Assessment of axillary lymph node metastasis in breast cancer using multicenter database, Ssada S, Masumoto N, Sasada T, Noma M, Ohara M, Shigematsu H, Matsuura K, Ozaki S, Kawabuchi Y, Kadoya T, Funakoshi M, Okada M, The 26th Annual Meeting of the Japanese Breast Cancer, 2018/05/17, Without Invitation, Japanese, Kyoto
  15. Preoperative diagnostic accuracy of axillary node metastasis in breast cancer: considering sentinel node biopsy, Sasada S, Masumoto N, Goda N, Kajitani K, Emi A, Haruta R, Kadoya T, Kataoka T, Okada M, The 118th Annual Congress of Japanese Surgical Society, 2018/04/06, Without Invitation, Japanese, Tokyo
  16. Stealth breast cancer on ring-type dedicated breast PET, Shinsuke Sasada, Takayuki Kadoya, Noriko Goda, Keiko Kajitani, Akiko Emi, Norio Masumoto, Rumi Haruta, Tsuyoshi Kataoka, Morihito Okada, ESMO ASIA 2017, 2017/11/18, Without Invitation, English, ESMO, Singapore
  17. Dedicated breast PET for predicting residual disease after breast cancer neoadjuvant chemotherapy, Shinsuke Sasada, Takayuki Kadoya, Noriko Goda, Akiko Emi, Keiko Kajitani, Norio Masumoto, Rumi Haruta, Tsuyoshi Kataoka, Morihito Okada, ESMO 2017 Congress, 2017/09/11, Without Invitation, English, ESMO, Mdrid
  18. Dose intensity of docetaxel plus cyclophosphamide therapy for early breast cancer, Sasada, S., Kadoya, T., Goda, N., Emi, A., Kajitani, K., Masumoto, N., Haruta, R., Kataoka, T., Okada, M., The 15th the Japanese Society of Medical Oncology Annual Meeting, 2017/07/27, Without Invitation, English, the Japanese Society of Medical Oncology, Kobe
  19. Diagnostic ability of breast cancer extension bin preoperative dedicated breast PET, Sasada, S., Kadoya, T., Murakami, C., Yoshikawa, T., Fujiwara, M., Handa, Y., Amioka, A., Goda, N., Kono, M., Emi, A., Kajitani, K., Masumoto, N., Haruta, R., Kataoka, T., Okada, M, The 25th Annual Meeting of the Japanese Breast Cancer, 2017/07/13, Without Invitation, Japanese, Japanese Breast Cancer Society, Fukuoka
  20. Extent diagnosis of breast cancer by preoperative dedicated breast PET, Sasada, S., Kadoya, T., Amioka, A., Goda, N., Emi, A., Kajitani, K., Masumoto, N., Haruta, R., Kataoka, T., Okada, M., The 117th Annual Congress of Japanese Surgical Society, 2017/04/27, Without Invitation, Japanese, Japanese Surgical Society, Yokohama
  21. Detectability of satellite lesions and intraductal spreading by dedicated breast PET, Sasada, S., Kadoya, T., Murakami, C., Goda, N., Emi, A., Kajitani, K., Masumoto, N., Kimura, M., Haruta, R., Kataoka, T., Okada, M., The 13th Annual Meeting of the Japanese Breast Cancer Society, Chugoku-Shikoku Branch, 2016/10/02, Without Invitation, Japanese, Japanese Breast Cancer Society, Chugoku-Shikoku Branch, Matsuyama
  22. Role of lepidic component in adjuvant chemotherapy for stage I lung adenocarcinoma: A propensity-score matching analysis, Sasada S, Miyata Y, Mimae T, Tsutani Y, Mimura T, Okada M, ECCO-ESMO 2015, 2015/09/27, Without Invitation, English, ECCO-ESMO, Vienna
  23. Peripheral neuropathy caused by vincristine-containing chemotherapy for adult soft tissue sarcoma: a comparison between young and older adults, Sasada S, Kodaira M, Shimoi T, Shimomura A, Yunokawa M, Yonemori K, Shimizu C, Fujiwara Y, Tamura K, ECCO-ESMO 2017, 2015/09/26, Without Invitation, English, ECCO-ESMO, Vienna
  24. Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma, Sasada S, Miyata Y, Mimae T, Tsutani Y, Mimura T, Okada M, WSCTS 2017, 2015/09/21, Without Invitation, English, WSCTS, Edinburgh
  25. Peripheral neuropathy of VAC therapy for adult rhabdomyosarcoma, Sasada S, Kodaira M, Hishimoto J, Yamamoto H, Yunokawa M, Yonemori K, Shimizu C, Fujiwara Y, Tamura K, The 13th the Japanese Society of Medical Oncology Annual Meeting, 2015/07/18, Without Invitation, English, Sapporo
  26. Chemotherapy for metastatic and recurrent urachal cancer, Sasada S, Hashimoto J, Kodaira M, Yamamoto H, Yunokawa M, Shimizu C, Tamura Y, The 115th Annual Congress of Japanese Surgical Society, 2015/04/18, Without Invitation, Japanese, Japanese Surgical Society, Nagoya
  27. Comparison of malignant grades between pure and partially invasive types of clinical stage IA lung adenocarcinoma, Sasada S, Nakayama H, Miyata Y, Tsubokawa N, Mimae T, Yoshiya T, Murakami S, Ito H, Okada M, ESMO 2014 Congress, 2014/09/29, Without Invitation, English, ESMO, Madrid

External Funds

Acceptance Results of Competitive Funds

  1. Grants-in-Aid for Scientific Research, Development of high-precision 3D image recognition function by a novel microwave breast imaging system, 2020/04, 2024/03
  2. Grants-in-Aid for Scientific Research, Non-invasive and portable breast cancer imaging system using weak microwave for communication, 2018/04, 2020/03
  3. Grants-in-Aid for Scientific Research, Metabolome analysis of molecular mechanism involved in invasion and metastasis of lung cancer cells, 2013/08/30, 2015/03/31
  4. Ryokufukai Education and Research Award, Analysis of biological malignancy and oncogenesis according to lepidic component in lung adenocarcinoma, 2013
  5. Abroad Research Grant, Role of lepidic component in adjuvant chemotherapy for stage I lung adenocarcinoma: A propensity-score analysis, etc, 2015
  6. ESMO Asia 2017, travel grant, Stealth breast cancer on ring-type dedicated breast PET, 2017
  7. Takeda Science Foundation, Development of optimization program for impulse-radar breast tumor detection system, 2018/09

Social Activities

Other Social Contributions

  1. Young Breast Cancer Survivors' Talks National Caravan, Young Breast Cancer Survivors' Talks National Caravan 2018 in Hiroshima, Pink Ring, 2018/07/01, Organizing Member, Meeting or assembly, General
  2. Machinaka Ribbon Salon, Machinaka Ribbon Salon, Hirshima Pinkribbon Project, 2011/07/02, Organizing Member, Meeting or assembly, General

History as Peer Reviews of Academic Papers

  1. 2022, Cancer Cell International, Others, 1
  2. 2022, International Journal of Clinical Oncology, Others, 2
  3. 2021, Breast Cancer, Others, 1
  4. 2021, BMJ Open, Others, 1
  5. 2021, Scientific Reports, Others, 1
  6. 2021, International Journal of Clinical Oncology, Others, 2
  7. 2021, Future Oncology, Others, 1
  8. 2021, Frontiers in Oncology, Others, 1
  9. 2021, BMC Cancer, Others, 1
  10. 2020, Scientific Reports, Others, 1
  11. 2020, Indian Journal of Medical Research, Others, 1
  12. 2019, Scientific Reports, Others, 1